Targeted Delivery of Thrombolytic Drug with Magnetic Nanoparticles in a Rat Embolic Model
碩士 === 長庚大學 === 基礎醫學研究所 === 96 === Recombinant tissue plasminogen activator (rtPA) has been used for thromboembolic diseases with hemorrhagic side effects. Magnetic nanoparticles (MNP) may serve as a carrier for target therapeutics to reduce the side effect and the amount of the drug used. We test...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/53083145490960083747 |